Except for one patient with endometrioid adenocarcinoma, which exhibited only HER2 overexpression, all patients with UC with a serous component or USPC had concordant HER2 IHC and HER2 SISH results (Table 3). This evidence concerns the gene ERBB2 and endometrioid adenocarcinoma.